Sirtuins: Possible clinical implications in cardio and cerebrovascular diseases

Valeria Conti, Maurizio Forte, Graziamaria Corbi, Giusy Russomanno, Luigi Formisano, Alessandro Landolfi, Viviana Izzo, Amelia Filippelli, Carmine Vecchione, Albino Carrizzo

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

Mammalian sirtuins (SIRT1-7) are NAD+-dependent deacetylases, which play an important role in aging and in a wide range of cellular functions. SIRT1, the best-characterized member of the family, acts as a sensor of the redox state and triggers in the cell the appropriate defense response. A large body of evidence has showed that SIRT1 induces both cellular and systemic protective effects in the cardiovascular system by preventing stress-induced apoptosis and senescence, and mitigating endothelial dysfunction. Hence, SIRT1 is now foreseen as a potential therapeutic target for a growing number of cardiovascular diseases. Recently, it has been suggested that SIRT1 activation could also be considered as a neuroprotective strategy. Indeed, SIRT1 protects against ischemia/reperfusion injury both in vitro and in vivo and avoids severe ischemic damage by preserving cerebral blood flow. In the last years it was suggested that others sirtuins, in particular SIRT3 and SIRT6, could exert beneficial effects in vascular syndromes. The aim of this review was to describe and discuss recent experimental evidence on the effects of SIRT1 and other sirtuins on the pathophysiology of cardio- and cerebrovascular diseases, underlying a potential therapeutic effect of these enzymes in the treatment and/or prevention of such conditions.

Original languageEnglish
Pages (from-to)473-484
Number of pages12
JournalCurrent Drug Targets
Volume18
Issue number4
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Sirtuins
Cerebrovascular Disorders
Cerebrovascular Circulation
Cardiovascular Diseases
Cardiovascular system
Therapeutic Uses
Cardiovascular System
Reperfusion Injury
NAD
Oxidation-Reduction
Blood Vessels
Blood
Aging of materials
Chemical activation
Apoptosis
Sensors
Enzymes
Therapeutics

Keywords

  • Drugs
  • SIRT1
  • SIRT3
  • SIRT6
  • Vascular function

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Sirtuins : Possible clinical implications in cardio and cerebrovascular diseases. / Conti, Valeria; Forte, Maurizio; Corbi, Graziamaria; Russomanno, Giusy; Formisano, Luigi; Landolfi, Alessandro; Izzo, Viviana; Filippelli, Amelia; Vecchione, Carmine; Carrizzo, Albino.

In: Current Drug Targets, Vol. 18, No. 4, 01.01.2017, p. 473-484.

Research output: Contribution to journalReview article

Conti, Valeria ; Forte, Maurizio ; Corbi, Graziamaria ; Russomanno, Giusy ; Formisano, Luigi ; Landolfi, Alessandro ; Izzo, Viviana ; Filippelli, Amelia ; Vecchione, Carmine ; Carrizzo, Albino. / Sirtuins : Possible clinical implications in cardio and cerebrovascular diseases. In: Current Drug Targets. 2017 ; Vol. 18, No. 4. pp. 473-484.
@article{cea6ace7128443ce92b3dee7284dacc0,
title = "Sirtuins: Possible clinical implications in cardio and cerebrovascular diseases",
abstract = "Mammalian sirtuins (SIRT1-7) are NAD+-dependent deacetylases, which play an important role in aging and in a wide range of cellular functions. SIRT1, the best-characterized member of the family, acts as a sensor of the redox state and triggers in the cell the appropriate defense response. A large body of evidence has showed that SIRT1 induces both cellular and systemic protective effects in the cardiovascular system by preventing stress-induced apoptosis and senescence, and mitigating endothelial dysfunction. Hence, SIRT1 is now foreseen as a potential therapeutic target for a growing number of cardiovascular diseases. Recently, it has been suggested that SIRT1 activation could also be considered as a neuroprotective strategy. Indeed, SIRT1 protects against ischemia/reperfusion injury both in vitro and in vivo and avoids severe ischemic damage by preserving cerebral blood flow. In the last years it was suggested that others sirtuins, in particular SIRT3 and SIRT6, could exert beneficial effects in vascular syndromes. The aim of this review was to describe and discuss recent experimental evidence on the effects of SIRT1 and other sirtuins on the pathophysiology of cardio- and cerebrovascular diseases, underlying a potential therapeutic effect of these enzymes in the treatment and/or prevention of such conditions.",
keywords = "Drugs, SIRT1, SIRT3, SIRT6, Vascular function",
author = "Valeria Conti and Maurizio Forte and Graziamaria Corbi and Giusy Russomanno and Luigi Formisano and Alessandro Landolfi and Viviana Izzo and Amelia Filippelli and Carmine Vecchione and Albino Carrizzo",
year = "2017",
month = "1",
day = "1",
doi = "10.2174/1389450116666151019095903",
language = "English",
volume = "18",
pages = "473--484",
journal = "Current Drug Targets",
issn = "1389-4501",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Sirtuins

T2 - Possible clinical implications in cardio and cerebrovascular diseases

AU - Conti, Valeria

AU - Forte, Maurizio

AU - Corbi, Graziamaria

AU - Russomanno, Giusy

AU - Formisano, Luigi

AU - Landolfi, Alessandro

AU - Izzo, Viviana

AU - Filippelli, Amelia

AU - Vecchione, Carmine

AU - Carrizzo, Albino

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Mammalian sirtuins (SIRT1-7) are NAD+-dependent deacetylases, which play an important role in aging and in a wide range of cellular functions. SIRT1, the best-characterized member of the family, acts as a sensor of the redox state and triggers in the cell the appropriate defense response. A large body of evidence has showed that SIRT1 induces both cellular and systemic protective effects in the cardiovascular system by preventing stress-induced apoptosis and senescence, and mitigating endothelial dysfunction. Hence, SIRT1 is now foreseen as a potential therapeutic target for a growing number of cardiovascular diseases. Recently, it has been suggested that SIRT1 activation could also be considered as a neuroprotective strategy. Indeed, SIRT1 protects against ischemia/reperfusion injury both in vitro and in vivo and avoids severe ischemic damage by preserving cerebral blood flow. In the last years it was suggested that others sirtuins, in particular SIRT3 and SIRT6, could exert beneficial effects in vascular syndromes. The aim of this review was to describe and discuss recent experimental evidence on the effects of SIRT1 and other sirtuins on the pathophysiology of cardio- and cerebrovascular diseases, underlying a potential therapeutic effect of these enzymes in the treatment and/or prevention of such conditions.

AB - Mammalian sirtuins (SIRT1-7) are NAD+-dependent deacetylases, which play an important role in aging and in a wide range of cellular functions. SIRT1, the best-characterized member of the family, acts as a sensor of the redox state and triggers in the cell the appropriate defense response. A large body of evidence has showed that SIRT1 induces both cellular and systemic protective effects in the cardiovascular system by preventing stress-induced apoptosis and senescence, and mitigating endothelial dysfunction. Hence, SIRT1 is now foreseen as a potential therapeutic target for a growing number of cardiovascular diseases. Recently, it has been suggested that SIRT1 activation could also be considered as a neuroprotective strategy. Indeed, SIRT1 protects against ischemia/reperfusion injury both in vitro and in vivo and avoids severe ischemic damage by preserving cerebral blood flow. In the last years it was suggested that others sirtuins, in particular SIRT3 and SIRT6, could exert beneficial effects in vascular syndromes. The aim of this review was to describe and discuss recent experimental evidence on the effects of SIRT1 and other sirtuins on the pathophysiology of cardio- and cerebrovascular diseases, underlying a potential therapeutic effect of these enzymes in the treatment and/or prevention of such conditions.

KW - Drugs

KW - SIRT1

KW - SIRT3

KW - SIRT6

KW - Vascular function

UR - http://www.scopus.com/inward/record.url?scp=85016051020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016051020&partnerID=8YFLogxK

U2 - 10.2174/1389450116666151019095903

DO - 10.2174/1389450116666151019095903

M3 - Review article

C2 - 26477463

AN - SCOPUS:85016051020

VL - 18

SP - 473

EP - 484

JO - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 4

ER -